Richard I. Fisher has stepped down from his roles as Fox Chase Cancer Center president and CEO, Fox Chase Cancer Center director, and senior associate dean for cancer programs at the Lewis Katz School of Medicine at Temple University.
Scott Lippman is transitioning from his role as director of Moores Cancer Center at UC San Diego Health to become the associate vice chancellor for cancer research and care, with the goal of formally launching the Precancer Genome Atlas.Â
Fifty-four organizations involved in health care sent a letter to the Senate leadership, urging confirmation of Robert Califf as FDA commissioner.
The World Health Organization designated Sylvester Comprehensive Cancer Center, a University of Miami institution, as the first WHO Collaborating Centre for Cervical Cancer Elimination.
Tara O. Henderson was named the service line chief of pediatric cancer and blood diseases at the Chicagoland Children’s Health Alliance, a collaboration between University of Chicago Medicine Comer Children’s Hospital, Advocate Children’s Hospital, and Pediatrics at NorthShore University HealthSystem.
Cleveland Clinic Cancer Center announced the following new staff appointments: Paolo Caimi, Kaleena Chilcote and Joel Saltzman
Jaye Gardiner, a postdoctoral researcher at Fox Chase Cancer Center, has received the inaugural Black in Cancer postdoctoral fellowship, which will provide $75,000 annually for three years to support her research into pancreatic ductal adenocarcinoma.
The Bristol Myers Squibb Foundation, together with its partners, National Medical Fellowships and the American Association for Cancer Research, selected 52 physicians for its Diversity in Clinical Trials Career Development Program. These early-stage investigators are the first of 250 community-oriented clinical trialists who will be trained through the program by 2027.
Orin Bloch, a neurosurgical oncologist and professor, has been appointed as the new co-leader of UC Davis Comprehensive Cancer Center’s Biomedical Technology Program.
NYU Langone Health’s Laura and Isaac Perlmutter Cancer Center opened a new center to treat people with blood cancers, including leukemia, lymphoma, and multiple myeloma.
